The effectiveness of botulinum toxin for chronic tension-type headache prophylaxis: A systematic review and meta-analysis
Cephalalgia · 2023
DOI: 10.1177/03331024221150231 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cephalalgia, 2023. Verfasst von Chathurika S Dhanasekara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA. Hauptthemen laut MEDLINE: Tension-Type Headache, Botulinum Toxins, Type A, Acute Pain, Headache Disorders. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
A systematic and meta-analysis was conducted to examine the evidence of the effects of botulinum toxin A on chronic tension-type headache.
Methods
Cochrane, Embase, Ovid, ProQuest, PubMed, Scopus, Web-of-Science databases, and ClinicallTrials.gov registry were systematically searched for studies examining the effects of botulinum toxin A on tension-type headaches. The records were screened by two independent reviewers using pre-determined eligibility criteria. DerSimonian Liard random-effects meta-analyses were performed using the ‘meta’ package (5.2-0) in R (4.2.0). Risk of bias and quality of evidence were assessed using the Cochrane Collaboration’s Tool RoB 2 and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Clinical significance was determined using pre-defined minimal clinically important differences.
Results
Eleven controlled trials were included (390 botulinum toxin A, 297 controls). Botulinum toxin A was associated with significant improvements in standardized headache intensity (−0.502 standard deviations [−0.945, −0.058]), headache frequency (−2.830 days/month [−4.082, −1.578]), daily headache duration (−0.965 [−1.860, −0.069]) and the frequency of acute pain medication use (−2.200 days/month [−3.485, −0.915]) vs controls. Botulinum toxin A-associated improvements exceeded minimal clinically important differences for headache intensity, frequency, and acute pain medication use. A 79% (28%, 150%) greater response rate was observed for botulinum toxin A vs controls in improving chronic tension-type headache. Treatment of eight chronic tension-type headache patients was sufficient to elicit a therapeutic response in one patient.
Conclusions
Corroborating the current mechanistic evidence, our meta-analysis supports the utility of botulinum toxin A for managing chronic tension-type headaches. However, due to limitations in the quality of evidence, adequately-powered high-quality controlled trials examining the effects of Botulinum toxin A on chronic tension-type headache are warranted. Registration Protocol preregistered in PROSPERO International Prospective Register of Systematic Reviews (CRD42020178616)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
- School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
- School of Medicine, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
- Department of Pathology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
- Center of Excellence for Integrative Health, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
- Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
ORCID-Profile: Chathurika S Dhanasekara
Zitieren
APA
Dhanasekara, C. S., Payberah, D., Chyu, J. Y., Shen, C. L., & Kahathuduwa, C. N. (2023). The effectiveness of botulinum toxin for chronic tension-type headache prophylaxis: A systematic review and meta-analysis. Cephalalgia. https://doi.org/10.1177/03331024221150231
Vancouver
Dhanasekara CS, Payberah D, Chyu JY, Shen CL, Kahathuduwa CN. The effectiveness of botulinum toxin for chronic tension-type headache prophylaxis: A systematic review and meta-analysis. Cephalalgia. 2023. doi:10.1177/03331024221150231
BibTeX
@article{Dhanasekara2023,
author = {Dhanasekara, Chathurika S and Payberah, Daniel and Chyu, Joanna Y and Shen, Chwan-Li and Kahathuduwa, Chanaka N},
title = {The effectiveness of botulinum toxin for chronic tension-type headache prophylaxis: A systematic review and meta-analysis},
journal = {Cephalalgia},
year = {2023},
doi = {10.1177/03331024221150231}
}
EUVIMED